Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Business Practice, Trends & Forecasts

Business-in-Brief

Approvals
  • The FDA has cleared 23andMe’s Personal Genome Service Pharmacogenetic Reports for the inclusion of information about genetic variants that may impact a patient’s ability to metabolize some medicines. The test does not describe an association between the detected variants and any specific drug, nor whether a person will or will not respond to a particular drug. It is intended to help inform discussions with healthcare providers.
  • A new gene therapy has been recommended for approval in Europe. Luxturna can be used in adults and children suffering from retinal dystrophy – an inherited disorder caused by RPE65 gene mutations, which usually leads to blindness. Novartis will be required to conduct follow ups on patients to ensure long-term safety and efficacy.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent seven years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register